These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9631155)

  • 1. Substance abuse is responsible for most pre-AIDS deaths among women with HIV infection in Providence, Rhode Island, USA.
    Mylonakis E; Koutkia P; Rich JD; Tashima KT; Fiore TC; Flanigan T; Carpenter CC
    AIDS; 1998 May; 12(8):958-9. PubMed ID: 9631155
    [No Abstract]   [Full Text] [Related]  

  • 2. [Causes of death in HIV-infected French drug users, 1995-2000].
    Lewden C; Bonnet F; Bevilacqua S; Heripret L; May T; Morlat P; Jougla E; Dabis F; Chêne G; Salmon D; ;
    Ann Med Interne (Paris); 2002 Nov; 153(7 Suppl):2S4-10. PubMed ID: 12518077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and management of substance use in HIV primary care.
    AIDS Inst Newsl; 1995 Jun; ():1-12. PubMed ID: 11367406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes and rates of death among methadone maintenance patients before and after the onset of the HIV/AIDS epidemic.
    Appel PW; Joseph H; Richman BL
    Mt Sinai J Med; 2000; 67(5-6):444-51. PubMed ID: 11064496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues.
    Celentano DD; Lucas G
    Clin Infect Dis; 2007 Dec; 45 Suppl 4():S318-23. PubMed ID: 18190306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of HIV and AIDS among high-risk populations in Rhode Island, 2002.
    Fulton JP; Chiaverini L; Loberti P; Minuto L
    Med Health R I; 2002 Oct; 85(10):324-5. PubMed ID: 12412526
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy].
    Muga R; Egea JM; Navío M; Sirera G; Vall M; Tor J
    Med Clin (Barc); 1999 May; 112(19):721-5. PubMed ID: 10394568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004.
    Bonnet F; Chêne G; Thiébaut R; Dupon M; Lawson-Ayayi S; Pellegrin JL; Dabis F; Morlat P;
    HIV Med; 2007 Nov; 8(8):547-54. PubMed ID: 17944688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the total mortality among problem drug users.
    Cruts G; Buster M; Vicente J; Deerenberg I; Van Laar M
    Subst Use Misuse; 2008; 43(5):733-47. PubMed ID: 18393087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver complications have reached a plateau as cause of hospital admission and death in HIV patients in Madrid.
    Núñez-Fernández C; Martín-Carbonero L; Valencia ME; Aguilera J; García-Samaniego J; Gonzalez-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2009 Apr; 25(4):383-5. PubMed ID: 19320566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
    Lewis KG; Weinstock MA
    Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).
    Michel L; Giorgi R; Villes V; Poizot-Martin I; Dellamonica P; Spire B; Protopopescu C; Carrieri MP
    Drug Alcohol Depend; 2009 Jan; 99(1-3):96-104. PubMed ID: 18774237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality among Hispanic drug users in Puerto Rico.
    Robles RR; Matos TD; Colón HM; Sahai H; Reyes JC; Marrero CA; Calderón JM
    P R Health Sci J; 2003 Dec; 22(4):369-76. PubMed ID: 14768503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance abuse and HIV infection.
    Francis H
    Top HIV Med; 2003; 11(1):20-4. PubMed ID: 12717047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States.
    Chorba TL; Holman RC; Clarke MJ; Evatt BL
    Am J Hematol; 2001 Apr; 66(4):229-40. PubMed ID: 11279632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.
    Katsarou O; Touloumi G; Antoniou A; Kouramba A; Hatzakis A; Karafoulidou A
    Haemophilia; 2005 Jul; 11(4):360-5. PubMed ID: 16011588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deaths caused by HIV disease under-reported in South Africa.
    Yudkin PL; Burger EH; Bradshaw D; Groenewald P; Ward AM; Volmink J
    AIDS; 2009 Jul; 23(12):1600-2. PubMed ID: 19521232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance abuse and HIV infection.
    Ferrando SJ; Batki SL
    New Dir Ment Health Serv; 2000; (87):57-67. PubMed ID: 11031802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discussion: subject selection, recruitment, and retention in longitudinal studies involving perinatal substance abuse and human immunodeficiency virus infection.
    Bandstra ES
    NIDA Res Monogr; 1992; 117():183-93. PubMed ID: 1620196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.